This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide.View CRL
Charles River Laboratories International In - CRL - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Charles River Laboratories International In as a
Buy with a ratings score of A.
Report Snippet: We rate CHARLES RIVER LABS INTL INC (CRL) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.